As a key initiative for our company, Peptineo is looking to bring a systems-based approach that includes computational modeling, pharmacology, protein engineering, and advanced drug carrier design to address unmet therapeutic challenges. From basic research to clinical trials, we strive to identify for our clients innovative approaches to address ever evolving conditions seen in the clinical community. Current activities include research into therapeutic peptides, reformulation of existing pharmacological compounds, and hybrid compounds that integrate modern, recombinant biological proteins with traditional chemical compounds.
Additionally, Peptineo offers consulting services to clientele that require outsourced research and development of newly developed biological compounds. Current activities include consulting in the areas of biotechnology, pharmaceutical research, peptide synthesis and related development efforts. We, also, as part of out consulting efforts, assist clients in areas of intellectual property to ensure that products developed as part of a contracted effort are protected for future use.